These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 39172599)

  • 1. Clinical significance of serum soluble scavenger receptor CD163 in patients with lupus nephritis.
    Liu Y; Li M; Zhang H; Yin Z; Wang X
    Lupus; 2024 Oct; 33(12):1279-1288. PubMed ID: 39172599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.
    Nishino A; Katsumata Y; Kawasumi H; Hirahara S; Kawaguchi Y; Yamanaka H
    Lupus; 2019 Jul; 28(8):986-994. PubMed ID: 31246559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.
    Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C
    Front Immunol; 2020; 11():671. PubMed ID: 32351512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease.
    David C; Divard G; Abbas R; Escoubet B; Chezel J; Chauveheid MP; Rouzaud D; Boutten A; Papo T; Dehoux M; Sacre K
    Scand J Rheumatol; 2020 Jan; 49(1):33-37. PubMed ID: 31161842
    [No Abstract]   [Full Text] [Related]  

  • 5. CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus.
    Nakayama W; Jinnin M; Makino K; Kajihara I; Makino T; Fukushima S; Sakai K; Inoue Y; Ihn H
    Eur J Dermatol; 2012; 22(4):512-7. PubMed ID: 22576016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated soluble CD163 predicts renal function deterioration in lupus nephritis: a cohort study in Eastern China.
    Yang G; Guo N; Yin J; Wu J
    J Int Med Res; 2021 Nov; 49(11):3000605211049963. PubMed ID: 34755559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis.
    Endo N; Tsuboi N; Furuhashi K; Shi Y; Du Q; Abe T; Hori M; Imaizumi T; Kim H; Katsuno T; Ozaki T; Kosugi T; Matsuo S; Maruyama S
    Nephrol Dial Transplant; 2016 Dec; 31(12):2023-2033. PubMed ID: 27242373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
    Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in sepsis, a prospective study.
    Feng L; Zhou X; Su LX; Feng D; Jia YH; Xie LX
    PLoS One; 2012; 7(7):e38400. PubMed ID: 22911680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus.
    Yang Z; Zhang Z; Qin B; Wu P; Zhong R; Zhou L; Liang Y
    J Clin Lab Anal; 2016 Nov; 30(6):897-904. PubMed ID: 27075413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis.
    Gupta R; Yadav A; Aggarwal A
    Clin Rheumatol; 2021 Mar; 40(3):941-948. PubMed ID: 32809146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis.
    Xue J; Yang J; Yang L; Zhou S; Ji C; Wang X; Yu N; Liu X; Chi S
    J Immunol Res; 2017; 2017():6861575. PubMed ID: 28373995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum CXCL9, CXCL10, and CXCL11 in patients with lupus nephritis.
    Wang S; Cui Y
    Immun Inflamm Dis; 2024 Aug; 12(8):e1368. PubMed ID: 39172029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
    Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
    J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of sTNF-R1 and linc0597 as indicators for disease activity and diagnosis of lupus nephritis.
    Zheng CZ; Yan WW; Luo YL; Wang TL; Shu YB
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5582-5591. PubMed ID: 32495893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
    Andersen MN; Abildgaard N; Maniecki MB; Møller HJ; Andersen NF
    Eur J Haematol; 2014 Jul; 93(1):41-7. PubMed ID: 24612259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.